Bloodstream Infection, Venous Thrombosis, and Peripherally Inserted Central Catheters: Reappraising the Evidence, The American Journal of Medicine, vol.125, issue.8, pp.733-774, 2012. ,
DOI : 10.1016/j.amjmed.2012.04.010
Advantages and disadvantages of peripherally inserted central venous catheters (PICC) compared to other central venous lines: A systematic review of the literature, Acta Oncologica, vol.149, issue.5, pp.886-92, 2013. ,
DOI : 10.1111/j.1538-7836.2010.04126.x
Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis, The Lancet, vol.382, issue.9889, pp.311-336, 2013. ,
DOI : 10.1016/S0140-6736(13)60592-9
Conclusions., Infection Control & Hospital Epidemiology, vol.60, issue.09, pp.908-926, 2013. ,
DOI : 10.1054/clnu.2000.0103
Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline, Journal of Clinical Oncology, vol.31, issue.10, pp.1357-70, 2013. ,
DOI : 10.1200/JCO.2012.45.5733
Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients, Supportive Care in Cancer, vol.15, issue.6, pp.1397-403, 2016. ,
DOI : 10.1007/s00520-015-2901-8
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries, 2012. ,
DOI : 10.1016/j.ejca.2012.12.027
URL : http://doi.org/10.1016/j.ejca.2012.12.027
Cancer survival in Europe 1999???2007 by country and age: results of EUROCARE-5???a population-based study, The Lancet Oncology, vol.15, issue.1, pp.23-34, 2014. ,
DOI : 10.1016/S1470-2045(13)70546-1
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.24, pp.7-23, 2013. ,
Accréditation et d'Evaluation en Santé (ANAES) Evaluation de la qualité de l'utilisation et de la surveillance des chambes à cathéter implantables, 2000. ,
Prévention des infections associées aux chambres à cathéter implantable pour un accès veineux: recommandations professionnels par consensus formalisé d'experts, pp.1-87, 2012. ,
Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter, Archives of Internal Medicine, vol.163, issue.16, 2003. ,
DOI : 10.1001/archinte.163.16.1913
Recommandations par consensus formalisé: bonne pratiques et gestion des risques associés au PICC (cathéter central à insertion périphérique), pp.1-124, 2013. ,
Vascular Access in Oncology Patients, CA: A Cancer Journal for Clinicians, vol.58, issue.6, pp.323-369, 2008. ,
DOI : 10.3322/CA.2008.0015
Patients??? perceptions of having a central venous catheter or a totally implantable subcutaneous port system???results from a randomised study in acute leukaemia, Supportive Care in Cancer, vol.7, issue.4 Pt 1, pp.137-180, 2009. ,
DOI : 10.1007/s00520-008-0449-6
Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement, Supportive Care in Cancer, vol.38, issue.12, 2016. ,
DOI : 10.1007/s00520-016-3368-y
Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies, Supportive Care in Cancer, vol.23, issue.1, pp.121-129, 2014. ,
DOI : 10.1007/s00520-013-1941-1
Marie-Caroline Husson Approche pharmaco-économique : évaluation pharmaco-médico-économique de stratégies thérapeutiques : éléments de méthodologie, pp.2000-2001 ,
Fiche d'économie de la santé n°1 : L'évaluation médico-économique, 2014. ,
Guide méthodologique -Choix méthodologiques pour l'évaluation économique à la HAS. Octobre, 2011. ,
Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days, Annals of Oncology, vol.9, issue.7, pp.767-73, 1998. ,
DOI : 10.1023/A:1008392423469
Cost Effectiveness of Different Central Venous Approaches for Port Placement and Use in Adult Oncology Patients: Evidence From a Randomized Three-Arm Trial, Annals of Surgical Oncology, vol.99, issue.1, pp.3725-3756, 2014. ,
DOI : 10.1245/s10434-014-3784-5
Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy, Journal of Thrombosis and Haemostasis, vol.2, issue.Suppl. 3B, pp.1281-1289, 2008. ,
DOI : 10.1111/j.1538-7836.2008.03053.x
Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters, Clinical Nutrition, vol.19, issue.4, pp.237-280, 2000. ,
DOI : 10.1054/clnu.2000.0103
CONCLUSION, Infection Control & Hospital Epidemiology, vol.34, issue.07, pp.811-818, 2016. ,
DOI : 10.1378/chest.12-0923
Improved Care and Reduced Costs for Patients Requiring Peripherally Inserted Central Catheters: the Role of Bedside Ultrasound and a Dedicated Team, Journal of Parenteral and Enteral Nutrition, vol.29, issue.5, pp.374-383, 2005. ,
DOI : 10.1053/crad.2001.0843
Care and cost-utility indicators for high-flow PICC catheters: a study, British Journal of Nursing, vol.20, issue.Sup1, pp.22-29, 2011. ,
DOI : 10.12968/bjon.2011.20.Sup1.S22
Impact of a Surgeon-Led Peripherally Inserted Central Venous Catheter Team on Peripherally Inserted Central Venous Catheter-Related Complications and Costs, Surgical Infections, vol.17, issue.3, pp.352-358, 2016. ,
DOI : 10.1089/sur.2015.093
Cost-effectiveness of employing a total parenteral nutrition surveillance nurse for the prevention of catheter-related bloodstream infections, Journal of Hospital Infection, vol.73, issue.2, pp.129-163, 2009. ,
DOI : 10.1016/j.jhin.2009.06.005
Peripherally inserted central catheters revisited, The American Journal of Surgery, vol.176, issue.2, pp.208-219, 1998. ,
DOI : 10.1016/S0002-9610(98)00121-4
Comparaison entre le co??t d???une pose de cath??ter veineux central d???insertion p??riph??rique et d???une chambre implantable, Annales Pharmaceutiques Fran??aises, vol.73, issue.3, pp.239-283, 2015. ,
DOI : 10.1016/j.pharma.2014.08.001
fr -Tarifs conventionnels des médecins généralistes en France métropolitaine. http://www.ameli.fr/professionnels-de-sante/medecins/votre-convention/tarifs/tarifsconventionnels-des-medecins-generalistes/tarifs-des-medecins-generalistes-enmetropole .php, 2016. ,
Reducing the risk of peripherally inserted central catheter line complications in the oncology setting, European Journal of Cancer Care, vol.72, issue.4, pp.342-349, 2006. ,
DOI : 10.1200/JCO.2002.11.135
Peripherally inserted central venous catheters in the acute care setting: A safe alternative to high-risk short-term central venous catheters, American Journal of Infection Control, vol.38, issue.2, pp.149-53, 2010. ,
DOI : 10.1016/j.ajic.2009.06.008
Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer, Thrombosis Research, vol.125, issue.4, pp.318-339, 2010. ,
DOI : 10.1016/j.thromres.2009.06.008
Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation, European Journal of Cancer Care, vol.20, issue.1, pp.125-157, 2013. ,
DOI : 10.1111/ecc.12008
Chlorhexidinesilver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy, Am J Infect Control, 2016. ,
DOI : 10.1016/j.ajic.2016.04.236
Cost-effectiveness of an antiseptic-impregnated central venous catheter in the ICU, Intensive Care Medicine, vol.29, issue.1, pp.139-139, 2003. ,
DOI : 10.1007/s00134-002-1559-0
Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA, BMJ Open, vol.4, issue.9, p.6065, 2014. ,
DOI : 10.1136/bmjopen-2014-006065